Kathleen M. Aguilar
Kathleen M. Aguilar publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Genetics, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #6,025,903 of 7,710,434 ranked researchers
- Rank in United States
- #1,465,450 of 1,627,098
- Works
- 66
- Citations
- 453
- Citations per work
- 6.9
What does Kathleen M. Aguilar research?
Kathleen M. Aguilar's work is mostly in Medicine (51%), Economics, Econometrics and Finance (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3450.8%
- Medicine3450.8%
- Everything else2841.7%
- Social Sciences57.5%
- 1Pulmonary and Respiratory Medicine14% of their works
- 2Oncology14% of their works
- 3Genetics8% of their works
- 4Surgery8% of their works
- 5Economics and Econometrics8% of their works
- 6Epidemiology7% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Lung Cancer Diagnosis and Treatment
- Bladder and Urothelial Cancer Treatments
Which keywords describe Kathleen M. Aguilar's research?
The keywords of their largest research topics: Chemotherapy, EGFR Mutations, Targeted Therapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Cost of Care, Cost-effectiveness Analysis and Financial Toxicity.
- Myelofibrosis
- JAK2 Mutation
- Diagnosis Criteria
- Bladder Cancer
- Financial Toxicity
- Cost of Care
- Immune Checkpoint Blockade
- EGFR Mutations
- Chemotherapy
- Targeted Therapy
- PD-1 and PD-L1
- Cost-effectiveness Analysis
- Quality of Life
- CT Screening
- International Myeloma Working Group
- Lung Cancer
- Urothelial Carcinoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Chemotherapy122 topics
- EGFR Mutations111 topic
- Targeted Therapy111 topic
- Immune Checkpoint Blockade101 topic
- PD-1 and PD-L1101 topic
- Cost of Care71 topic
- Cost-effectiveness Analysis71 topic
- Financial Toxicity71 topic
- Quality of Life71 topic
- Bladder Cancer61 topic
- CT Screening61 topic
- Diagnosis Criteria61 topic
- International Myeloma Working Group61 topic
- JAK2 Mutation61 topic
- Lung Cancer61 topic
- Myelofibrosis61 topic
- Urothelial Carcinoma61 topic
Where does Kathleen M. Aguilar work?
Kathleen M. Aguilar's main affiliation in the publication record is McKesson (United States), United States.
How many publications and citations does Kathleen M. Aguilar have?
OpenAlex counts 66 works and 453 citations for Kathleen M. Aguilar, an h-index of 10, ranking #6,025,903 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kathleen M. Aguilar. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.